Testosterone replacement for older men with sarcopenia
Phase of Trial: Phase IV
Latest Information Update: 01 Mar 2017
At a glance
- Drugs Testosterone (Primary)
- Indications Hypogonadism
- Focus Therapeutic Use
- Acronyms TOM
- 22 Feb 2017 Status changed from completed to discontinued because of higher incidence of cardiovascular events in the testosterone arm of the trial.
- 07 Jun 2011 Results presented at the 93rd Annual Meeting of the Endocrine Society.
- 30 Jun 2010 Tolerability results published in the New England Journal of Medicine.